467 related articles for article (PubMed ID: 8412313)
21. Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved.
Ouspenskaia MV; Johnston DA; Roberts WM; Estrov Z; Zipf TF
Leukemia; 1995 Feb; 9(2):321-8. PubMed ID: 7869771
[TBL] [Abstract][Full Text] [Related]
22. Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias.
Macintyre EA; d'Auriol L; Duparc N; Leverger G; Galibert F; Sigaux F
J Clin Invest; 1990 Dec; 86(6):2125-35. PubMed ID: 2174915
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of rearrangement of immunoglobulin genes and T cell receptors in determining low numbers of leukemic in children with acute lymphoblastic leukemia].
Podraza W; Osipowicz E; Ptaszyński K; Lubiński J; Fydryk J
Pol Tyg Lek; 1991 Dec 2-9; 46(48-49):929-30. PubMed ID: 1845710
[TBL] [Abstract][Full Text] [Related]
24. Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: proposal for an easy strategy.
Szczepański T; Willemse MJ; Kamps WA; van Wering ER; Langerak AW; van Dongen JJ
Med Pediatr Oncol; 2001 Mar; 36(3):352-8. PubMed ID: 11241436
[TBL] [Abstract][Full Text] [Related]
25. Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.
van der Velden VH; Szczepanski T; Wijkhuijs JM; Hart PG; Hoogeveen PG; Hop WC; van Wering ER; van Dongen JJ
Leukemia; 2003 Sep; 17(9):1834-44. PubMed ID: 12970784
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin gene rearrangement in detection of minimal residual disease in acute lymphoblastic leukaemia.
Nayyar A; Ahmed S
J Ayub Med Coll Abbottabad; 2013; 25(1-2):159-61. PubMed ID: 25098084
[TBL] [Abstract][Full Text] [Related]
27. In vitro amplification of T cell gamma gene rearrangements: a new tool for the assessment of minimal residual disease in acute lymphoblastic leukemias.
d'Auriol L; Macintyre E; Galibert F; Sigaux F
Leukemia; 1989 Feb; 3(2):155-8. PubMed ID: 2536129
[TBL] [Abstract][Full Text] [Related]
28. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
[TBL] [Abstract][Full Text] [Related]
29. Rearrangements of IgH, TCRD and TCRG genes as clonality marker of childhood acute lymphoblastic leukemia.
Meleshko AN; Lipay NV; Stasevich IV; Potapnev MP
Exp Oncol; 2005 Dec; 27(4):319-24. PubMed ID: 16404354
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of heavy chain immunoglobulins gene and T-cell receptor delta gene in children with acute leukemia].
Pan Q; Chou Y; Hong W
Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):529-31, 573. PubMed ID: 8556542
[TBL] [Abstract][Full Text] [Related]
31. Gamma and delta chain gene rearrangement of T cell receptor in acute lymphoblastic leukemia.
Tong JH; Dong S; Chen Y; Qian ZZ; Gu LJ; Zhang YM; Wang ZY; Chen SJ; Chen Z
Chin Med J (Engl); 1994 Jan; 107(1):12-8. PubMed ID: 8187567
[TBL] [Abstract][Full Text] [Related]
32. The use of monoclonal gene rearrangement for detection of minimal residual disease in acute lymphoblastic leukemia of childhood.
Sykes PJ; Snell LE; Brisco MJ; Neoh SH; Hughes E; Dolman G; Peng LM; Bennett A; Toogood I; Morley AA
Leukemia; 1997 Jan; 11(1):153-8. PubMed ID: 9001432
[TBL] [Abstract][Full Text] [Related]
33. [Preliminary results of the use of MRD test among children with acute lymphoblastic leukaemia].
Raciborska A; Wypych A; Rokicka-Milewska R; Siedlecki JA; Kulik J
Przegl Lek; 2004; 61 Suppl 2():62-6. PubMed ID: 15686049
[TBL] [Abstract][Full Text] [Related]
34. [Detection of TCR gamma gene in acute lymphoblastic leukemia after remission and its clinical significance].
Liu L; Sun J; Yin H
Zhonghua Xue Ye Xue Za Zhi; 1998 Jul; 19(7):353-5. PubMed ID: 11189517
[TBL] [Abstract][Full Text] [Related]
35. [Children with acute lymphoblastic leukemia: prognostic significance of polymerase-chain-reaction analysis of minimal residual disease].
Steenbergen EJ; Verhagen OJ; van den Berg H; van Leeuwen EF; von dem Borne AE; van der Schoot CE
Ned Tijdschr Geneeskd; 1996 Jan; 140(1):22-8. PubMed ID: 8569906
[TBL] [Abstract][Full Text] [Related]
36. Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions.
Seriu T; Hansen-Hagge TE; Erz DH; Bartram CR
Leukemia; 1995 Feb; 9(2):316-20. PubMed ID: 7869770
[TBL] [Abstract][Full Text] [Related]
37. Study of minimal residual disease in B-cell lineage acute lymphoblastic leukemia of childhood, using clone-specific probes.
Botsonis T; Tsangaris GT; Mikraki V; Tzortzatou-Stathopoulou F
Anticancer Res; 1999; 19(3B):2211-20. PubMed ID: 10472333
[TBL] [Abstract][Full Text] [Related]
38. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
[TBL] [Abstract][Full Text] [Related]
39. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia.
Roberts WM; Estrov Z; Ouspenskaia MV; Johnston DA; McClain KL; Zipf TF
N Engl J Med; 1997 Jan; 336(5):317-23. PubMed ID: 9011783
[TBL] [Abstract][Full Text] [Related]
40. [Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene].
Matolcsy A; Borbényi Z; Demeter J; Egyed M; Fekete S; Földi J; Gergely L; Kajtár P; Kelényi G; Kiss A; László T; Lehoczky D; Losonczy H; Nagy M; Pál K; Pálóczy K; Radványi G; Semsei I; Varga G; Udvardy M
Orv Hetil; 2000 Jun; 141(25):1403-6. PubMed ID: 10934884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
